SCHEMBL4365292

SCHEMBL4365292

CCOC(=O)c1cc(O)c(OC2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)c(OC2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMPRSS2 O15393 1/20 0.51
▸ USP2 O75604 1/20 0.51
▸ PDE5A O76074 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ HMGCR P04035 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ HSPD1 P10809 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CA6 P23280 1/20 0.51
▸ TBXAS1 P24557 1/20 0.51
▸ MAPK3 P27361 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HSPE1 P61604 1/20 0.51
▸ MAPK14 Q16539 1/20 0.51
▸ TST Q16762 1/20 0.51
▸ SLCO1B3 Q9NPD5 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366911 1.00 TMPRSS2 (0.51) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4366878 0.92 TMPRSS2 (0.49) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4368270 0.92 TMPRSS2 (0.49) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4364093 0.92 CYP2C9 (0.50) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4366877 0.92 CYP2C9 (0.50) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4362777 0.90 F11 (0.53) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4371275 0.90 F11 (0.53) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4367146 0.89 P4HB (0.48) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4379633 0.89 P4HB (0.48) TMPRSS2USP2PDE5ACA1CA2
SCHEMBL4366849 0.85 CYP2C9 (0.56) TMPRSS2USP2PDE5ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622563-B2 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2009-11-24 — — US disclosed
US-20050272921-A1 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2005-12-08 — — US disclosed
EP-1544207-A1 PROCESS FOR PRODUCING GLYCOSIDE Mitsui Chemicals, Inc. (JP) 2005-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272921-A1 Process for producing glycoside HAAO, OGA, MGAM TMPRSS2 3225/4885USP2 1058/4885PDE5A 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback